M57K (p.Met57Lys) variant of GCK (Hexokinase-4)

M57K (p.Met57Lys) in GCK (Hexokinase-4) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as likely pathogenic in the context of Monogenic diabetes. The available variant effect predictions contribute to a CATVariant prioritization score of 0.74 / 1. The record also includes population frequency data and structural context.

M57K (p.Met57Lys) variant details